Infant Exposure to MS Drugs via Breastfeeding: New Data : vimarsana.com

Infant exposure to monoclonal antibodies used to treat MS via breast milk does not negatively affect health or development out to 3 years, a new study shows.

Related Keywords

Illinois , United States , Northwestern University , Germany , Chicago , American , German , Kerstin Hellwig , Edithl Graham , Ruhr University In Bochum , American Academy Of Neurology , Department Of Neurology , Ruhr University , American Academy , Pregnancy Registry , Multiple Sclerosis ,